← Browse by Condition
Medical Condition
rhabdomyosarcoma
Total Trials
8
Recruiting Now
8
Trial Phases
Phase 1, Phase 1, Phase 2, Phase 3
NCT06441331 Phase 1
Recruiting
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
Enrollment
20 pts
Location
United States, Spain
Sponsor
ITM Solucin GmbH
NCT06865664 Phase 1
Recruiting
FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma
Enrollment
50 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT06541262 Phase 1, Phase 2
Recruiting
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Enrollment
104 pts
Location
United States, Canad...
Sponsor
Milton S. Hershey Medical Cent...
NCT04337177 Phase 1
Recruiting
Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
Enrollment
20 pts
Location
United States
Sponsor
Valent Technologies, LLC
NCT04625907 Phase 1, Phase 2
Recruiting
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
Enrollment
1,672 pts
Location
Australia, Austria, ...
Sponsor
University of Birmingham
NCT06836492 Phase 3
Recruiting
A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors.
Enrollment
300 pts
Location
China
Sponsor
Yizhuo Zhang
NCT03050268
Recruiting
Familial Investigations of Childhood Cancer Predisposition
Enrollment
1,500 pts
Location
United States
Sponsor
St. Jude Children's Research H...
NCT06796543
Recruiting
Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma
Enrollment
70 pts
Location
United States
Sponsor
Sidney Kimmel Comprehensive Ca...